Back to Search Start Over

Metabotypes of flavan-3-ol colonic metabolites after cranberry intake: elucidation and statistical approaches.

Authors :
Mena, Pedro
Favari, Claudia
Acharjee, Animesh
Chernbumroong, Saisakul
Bresciani, Letizia
Curti, Claudio
Brighenti, Furio
Heiss, Christian
Rodriguez-Mateos, Ana
Del Rio, Daniele
Source :
European Journal of Nutrition; Apr2022, Vol. 61 Issue 3, p1299-1317, 19p, 3 Diagrams, 3 Charts, 2 Graphs
Publication Year :
2022

Abstract

Purpose: Extensive inter-individual variability exists in the production of flavan-3-ol metabolites. Preliminary metabolic phenotypes (metabotypes) have been defined, but there is no consensus on the existence of metabotypes associated with the catabolism of catechins and proanthocyanidins. This study aims at elucidating the presence of different metabotypes in the urinary excretion of main flavan-3-ol colonic metabolites after consumption of cranberry products and at assessing the impact of the statistical technique used for metabotyping. Methods: Data on urinary concentrations of phenyl-γ-valerolactones and 3-(hydroxyphenyl)propanoic acid derivatives from two human interventions has been used. Different multivariate statistics, principal component analysis (PCA), cluster analysis, and partial least square-discriminant analysis (PLS-DA), have been considered. Results: Data pre-treatment plays a major role on resulting PCA models. Cluster analysis based on k-means and a final consensus algorithm lead to quantitative-based models, while the expectation–maximization algorithm and clustering according to principal component scores yield metabotypes characterized by quali-quantitative differences in the excretion of colonic metabolites. PLS-DA, together with univariate analyses, has served to validate the urinary metabotypes in the production of flavan-3-ol metabolites and to confirm the robustness of the methodological approach. Conclusions: This work proposes a methodological workflow for metabotype definition and highlights the importance of data pre-treatment and clustering methods on the final outcomes for a given dataset. It represents an additional step toward the understanding of the inter-individual variability in flavan-3-ol metabolism. Trial registration: The acute study was registered at clinicaltrials.gov as NCT02517775, August 7, 2015; the chronic study was registered at clinicaltrials.gov as NCT02764749, May 6, 2016. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14366207
Volume :
61
Issue :
3
Database :
Complementary Index
Journal :
European Journal of Nutrition
Publication Type :
Academic Journal
Accession number :
155757619
Full Text :
https://doi.org/10.1007/s00394-021-02692-z